Gigaxonin controls vimentin organization through a tubulin chaperone-independent pathway

Human Molecular Genetics

Volumn 18, Issue 8, 2009, Pages 1384-1394

  Cleveland, Don W ^a   Yamanaka, Koji ^a,b,c   Bomont, Pascale ^a,d,e  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (United States)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d Turing Center for Living Systems CENTURI Aix Marseille University   (France)

^e AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CHAPERONE; GIGAXONIN; MICROTUBULE ASSOCIATED PROTEIN 5; MICROTUBULE ASSOCIATED PROTEIN 8; MICROTUBULE PROTEIN; PROTEIN TBCB; TUBULIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; VIMENTIN;

ANIMAL CELL; ARTICLE; CELL STRAIN COS1; CONTROLLED STUDY; DEGENERATIVE DISEASE; DIAGNOSTIC TEST; FIBROBLAST CULTURE; GENE MUTATION; GIANT AXONAL NEUROPATHY; HUMAN; HUMAN CELL; INTERMEDIATE FILAMENT; MICROTUBULE ASSEMBLY; MUTATIONAL ANALYSIS; NERVE BIOPSY; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION;

CYTOSKELETAL PROTEINS; FIBROBLASTS; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; MICROTUBULES; MOLECULAR CHAPERONES; NEURODEGENERATIVE DISEASES; VIMENTIN;

EID: 64549164076     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddp044     Document Type: Article

References (52)

1. Asbury, A.K., Gale, M.K., Cox, S.C., Baringer, J.R. and Berg, B.O. (1972) Giant axonal neuropathy, a unique case with segmental neurofilamentous masses. Acta Neuropathol., 20, 237-247.
2. Ben Hamida, C., Cavalier, L., Belal, S., Sanhaji, H., Nadal, N., Barhoumi, C., MRissa, N., Marzouki, N., Mandel, J.L., Ben Hamida, M. et al. (1997) Homozygosity mapping of giant axonal neuropathy gene to chromosome 16q24.1. Neurogenetics, 1, 129-133.
3. Berg, B.O., Rosenberg, S.H. and Asbury, A.K. (1972) Giant axonal neuropathy. Pediatrics, 49, 894-899.
4. Bomont, P., Cavalier, L., Blondeau, F., Ben Hamida, C., Belal, S., Tazir, M., Demir, E., Topaloglu, H., Korinthenberg, R., Tuysuz, B. et al. (2000) The gene encoding gigaxonin, a new member of the cytoskeletal BTB/Kelch repeat family, is mutated in giant axonal neuropathy. Nat. Genet., 26, 370-374.
5. Igisu, H., Ohta, M., Tabira, T., Hosokawa, S. and Goto, I. (1975) Giant axonal neuropathy. A clinical entity affecting the central as well as the peripheral nervous system. Neurology, 25, 717-721.
6. Ouvrier, R.A., Prineas, J., Walsh, J.C., Reye, R.D. and McLeod, J.G. (1974) Giant axonal neuropathy, a third case. Proc. Aust. Assoc. Neurol., 11, 137-144.
7. Koch, T., Schultz, P., Williams, R. and Lampert, P. (1977) Giant axonal neuropathy, a childhood disorder of microfilaments. Ann. Neurol., 1, 438-451.
8. Peiffer, J., Schlote, W., Bischoff, A., Boltshauser, E. and Muller, G. (1977) Generalized giant axonal neuropathy, a filament-forming disease of neuronal, endothelial, glial, and schwann cells in a patient without kinky hair. Acta Neuropathol., 40, 213-218.
9. Azzedine, H., Ravise, N., Verny, C., Gabreels-Festen, A., Lammens, M., Grid, D., Vallat, J.M., Durosier, G., Senderek, J., Nouioua, S. et al. (2006) Spine deformities in Charcot-Marie-Tooth 4C caused by SH3TC2 gene mutations. Neurology, 67, 602-606.
10. Fabrizi, G.M., Cavallaro, T., Angiari, C., Bertolasi, L., Cabrini, I., Ferrarini, M. and Rizzuto, N. (2004) Giant axon and neurofilament accumulation in Charcot-Marie-Tooth disease type 2E. Neurology, 62, 1429-1431.
11. Fabrizi, G.M., Cavallaro, T., Angiari, C., Cabrini, I., Taioli, F., Malerba, G., Bertolasi, L. and Rizzuto, N. (2007) Charcot-Marie-Tooth disease type 2E, a disorder of the cytoskeleton. Brain, 130, 394-403.
12. Lus, G., Nelis, E., Jordanova, A., Lofgren, A., Cavallaro, T., Ammendola, A., Melone, M.A., Rizzuto, N., Timmerman, V., Cotrufo, R. et al. (2003) Charcot-Marie-Tooth disease with giant axons, a clinicopathological and genetic entity. Neurology, 61, 988-990.
13. Lariviere, R.C. and Julien, J.P. (2004) Functions of intermediate filaments in neuronal development and disease. J. Neurobiol., 58, 131-148.
14. Bomont, P. and Koenig, M. (2003) Intermediate filament aggregation in fibroblasts of giant axonal neuropathy patients is aggravated in non dividing cells and by microtubule destabilization. Hum. Mol. Genet. 12, 813-822.
15. Prineas, J.W., Ouvrier, R.A., Wright, R.G., Walsh, J.C. and McLeod, J.G. (1976) Giant axonal neuropathy, a generalized disorder of cytoplasmic microfilament formation. J. Neuropathol. Exp. Neurol., 35, 458-470.
16. Klymkowsky, M.W. and Plummer, D.J. (1985) Giant axonal neuropathy, a conditional mutation affecting cytoskeletal organization. J. Cell Biol., 100, 245-250.
17. Pena, S.D. (1981) Giant axonal neuropathy, intermediate filament aggregates in cultured skin fibroblasts. Neurology, 31, 1470-1473.
18. Pena, S.D., Opas, M., Turksen, K., Kalnins, V.I. and Carpenter, S. (1983) Immunocytochemical studies of intermediate filament aggregates and their relationship to microtubules in cultured skin fibroblasts from patients with giant axonal neuropathy. Eur. J. Cell Biol., 31 227-234.
19. Bomont, P., Ioos, C., Yalcinkaya, C., Korinthenberg, R., Vallat, J.M., Assami, S., Munnich, A., Chabrol, B., Kurlemann, G., Tazir, M. et al. (2003) Identification of seven novel mutations in the GAN gene. Hum. Mutat., 21, 446-451.
20. Bruno, C., Bertini, E., Federico, A., Tonoli, E., Lispi, M.L., Cassandrini, D., Pedemonte, M., Santorelli, F.M., Filocamo, M., Dotti, M.T. et al. (2004) Clinical and molecular findings in patients with giant axonal neuropathy (GAN). Neurology, 62, 13-16.
21. Demir, E., Bomont, P., Erdem, S., Cavalier, L., Demirci, M., Kose, G., Muftuoglu, S., Cakar, A.N., Tan, E., Aysun, S. et al. (2005) Giant axonal neuropathy: Clinical and genetic study in six cases. J. Neurol. Neurosurg. Psychiatr., 76, 825-832.
22. Houlden, H., Groves, M., Miedzybrodzka, Z., Roper, H., Willis, T., Winer, J., Cole, G. and Reilly, M.M. (2007) New mutations, genotype phenotype studies and manifesting carriers in giant axonal neuropathy. J. Neurol. Neurosurg. Psychiatr., 78, 1267-1270.
23. Koop, O., Schirmacher, A., Nelis, E., Timmerman, V., De Jonghe, P., Ringelstein, B., Rasic, V.M., Evrard, P., Gärtner, J., Claeys, K.G. et al. (2007) Genotype-phenotype analysis in patients with giant axonal neuropathy. Neuromuscul. Disord., 17, 624-630.
24. Kuhlenbaumer, G., Young, P., Oberwittler, C., Hunermund, G., Schirmacher, A., Domschke, K., Ringelstein, B. and Stogbauer, F. (2002) Giant axonal neuropathy (GAN), case report and two novel mutations in the gigaxonin gene. Neurology, 58, 1273-1276.
25. Leung, C.L., Pang, Y., Shu, C., Goryunov, D. and Liem, R.K. (2007) Alterations in lipid metabolism gene expression and abnormal lipid accumulation in fibroblast explants from giant axonal neuropathy patients. BMC Genet., 8, 6-10.
26. Nalini, A., Gayathri, N., Yasha, T.C., Ravishankar, S., Urtizberea, A., Huehne, K. and Rautenstrauss, B. (2008) Clinical, pathological and molecular findings in two siblings with giant axonal neuropathy (GAN), report from India. Eur. J. Med. Genet., 51, 426-435.
27. McClellan, A.J., Tam, S., Kaganovich, D. and Frydman, J. (2005) Protein quality control, chaperones culling corrupt conformations. Nat. Cell Biol., 7, 736-741.
28. Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y. and Shimizu, N. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature, 9, 605-608.
29. Furukawa, M., He, Y.J., Borchers, C. and Xiong, Y. (2003) Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin ligases. Nat. Cell Biol., 5, 1001-1007.
30. Pintard, L., Willis, J.H., Willems, A., Johnson, J.L., Srayko, M., Kurz, T., Glaser, S., Mains, P.E., Tyers, M., Bowerman, B. et al. (2003) The BTB protein MEL-26 is a substrate-specific adaptor of the CUL-3 ubiquitin-ligase. Nature, 425, 311-316.
31. Xu, L., Wei, Y., Reboul, J., Vaglio, P., Shin, T.H., Vidal, M., Elledge, S.J. and Harper, J.W. (2003) BTB proteins are substrate-specific adaptors in an SCF-like modular ubiquitin ligase containing CUL-3. Nature, 425, 316-321.
32. Allen, E., Ding, J., Wang, W., Pramanik, S., Chou, J., Yau, V. and Yang, Y. (2005) Gigaxonin-controlled degradation of MAP1B light chain is critical to neuronal survival. Nature, 438, 224-228.
33. Ding, J., Allen, E., Wang, W., Valle, A., Wu, C., Nardine, T., Cui, B., Yi, J., Taylor, A., Jeon, N.L. et al. (2006) Gene targeting of GAN in mouse causes a toxic accumulation of microtubule-associated protein 8 and impaired retrograde axonal transport. Hum. Mol. Genet., 15 1451-1463.
34. Wang, W., Ding, J., Allen, E., Zhu, P., Zhang, L., Vogel, H. and Yang, Y. (2005) Gigaxonin interacts with tubulin folding cofactor B and controls its degradation through the ubiquitin-proteasome pathway. Curr. Biol., 15, 2050-2055.
35. Ding, J., Liu, J.J., Kowal, A.S., Nardine, T., Bhattacharya, P., Lee, A. and Yang, Y. (2002) Microtubule-associated protein 1B, a neuronal binding partner for gigaxonin. J. Cell Biol., 158, 427-433.
36. Kortazar, D., Fanarraga, M.L., Carranza, G., Bellido, J., Villegas, J.C., Avila, J. and Zabala, J.C. (2007) Role of cofactors B (TBCB) and E (TBCE) in tubulin heterodimer dissociation. Exp. Cell Res., 313 425-436.
37. Dequen, F., Bomont, P., Gowing, G., Cleveland, D.W. and Julien, J.P. (2008) Modest loss of peripheral axons, muscle atrophy and formation of brain inclusions in mice with targeted deletion of gigaxonin exon 1. J. Neurochem., 107, 253-264.
38. Gurland, G. and Gundersen, G.G. (1995) Stable, detyrosinated microtubules function to localize vimentin intermediate filaments in fibroblasts. J. Cell Biol., 131, 1275-1290.
39. Gyoeva, F.K. and Gelfand, V.I. (1991) Coalignment of vimentin intermediate filaments with microtubules depends on kinesin. Nature 353, 445-448.
40. Ho, C.L., Martys, J.L., Mikhailov, A., Gundersen, G.G. and Liem, R.K. (1998) Novel features of intermediate filament dynamics revealed by green fluorescent protein chimeras. J. Cell Sci., 111, 1767-1778.
41. Klymkowski, M. (1981) Intermediate filaments in 3T3 cells collapse after intracellular injection of a monoclonal anti-intermediate filament antibody. Nature, 249, 249-251.
42. Kreitzer, G., Liao, G. and Gundersen, G.G. (1999) Detyrosination of tubulin regulates the interaction of intermediate filaments with microtubules in vivo via a kinesin dependent mechanism. Mol. Biol. Cell, 10, 1105-1118.
43. Roy, S. (1993) Role of stress fibers in the association of intermediate filaments with microtubules in fibroblasts cells. Cell Biol. Int., 17, 645-652.
44. Yoon, M., Moir, R.D., Prahlad, V. and Goldman, R.D. (1998) Motile properties of vimentin intermediate filament networks in living cells. J. Cell Biol., 143, 147-157.
45. Bhamidipati, A., Lewis, S.A. and Cowan, N.J. (2000) ADP ribosylation factor-like protein 2 (Arl2) regulates the interaction of tubulin-folding cofactor D with native tubulin. J. Cell Biol., 149, 1087-1096.
46. Tian, G., Lewis, S.A., Feierbach, B., Stearns, T., Rommelaere, H., Ampe, C. and Cowan, N.J. (1997) Tubulin subunits exist in an activated conformational state generated and maintained by protein cofactors. J. Cell Biol., 138, 821-832.
47. Cullen, V.C., Brownlees, J., Banner, S., Anderton, B.H., Leigh, P.N., Shaw, C.E. and Miller, C.C. (2004) Gigaxonin is associated with the Golgi and dimerises via its BTB domain. Neuroreport, 15, 873-876.
48. Donaghy, M., King, R.H., Thomas, P.K. and Workman, J.M. (1988) Abnormalities of the axonal cytoskeleton in giant axonal neuropathy. J. Neurocytol., 17, 197-208.
49. Treiber-Held, S., Budjarjo-Welim, H., Reimann, D., Richter, J., Kretzschmar, H.A. and Hanefeld, F. (1994) Giant axonal neuropathy, a generalized disorder of intermediate filaments with longitudinal grooves in the hair. Neuropediatrics, 25, 89-93.
50. Tian, G., Huang, Y., Rommelaere, H., Vandekerckhove, J., Ampe, C. and Cowan, N.J. (1996) Pathway leading to correctly folded beta tubulin. Cell, 86, 287-296.
51. Bartolini, F., Tian, G., Piehl, M., Cassimeris, L., Lewis, S.A. and Cowan, N.J. (2005) Identification of a novel tubulin destabilizing protein related to the chaperone cofactor E. J. Cell Sci., 118 1197-1207.
52. Martin, L., Fanarraga, M.L., Aloria, K. and Zabala, J.C. (2000) Tubulin folding cofactor D is a microtubule destabilizing protein. FEBS Lett. 470, 93-95.